Should You Buy CVS Health Stock After Q1 Beat?

The investors were more than happy with CVS’ Q1 performance as well as revised guidance, and the stock rose 4%, post the earnings announcement. Now that over 44% of the U.S. population has received at least one dose of vaccine, the company’s retail sales are expected to rise, boding well for CVS… Forbes – Money | Read More

Similar Posts

Leave a Reply

Your email address will not be published.